Following the decision by the Food and Drug Administration (FDA) in the United States to approve a new drug - aducanumab – for the treatment of Alzheimer’s disease, we've worked with a group of Alzheimer's disease experts to compile a resource of 'Frequently Asked Questions'.
For accurate, reliable and balanced information on this new treatment, and what this recent approval means for people in Scotland, visit our aducanumab page.
View our aducanumab FAQs